The Personal Injury Wire

Depo-Provera: A Tentative Settlement, a Hearing That Still Matters, and 5,500 Plaintiffs Waiting for Answers

MDL-3140  |  Northern District of Florida  |  Judge M. Casey Rodgers

On June 15, 2026, Judge M. Casey Rodgers confirmed that Pfizer and the plaintiffs' leadership team had struck a global settlement in principle within the federal Depo-Provera meningioma MDL. The timing caught the mass tort bar off guard - no bellwether trials had taken place, no Daubert ruling had issued, and Pfizer's preemption motion remained pending. Pfizer emphasized the agreement carries no admission of liability and does not affect cases moving through state courts.

The details remain sealed. The global agreement covers roughly 3,400 lawsuits but explicitly excludes state court actions, most of which are pending in New York and Delaware. Plaintiffs allege the injectable contraceptive causes meningioma brain tumors and that Pfizer failed to warn patients for decades despite mounting science dating back to 1983.

A settlement in principle does not close the book on the litigation. The court still intends to hold a Rule 702 Daubert hearing on general causation, rescheduled for July 27, 2026, in Pensacola. The ruling will determine whether non-settling claims advance to bellwether trials in both the federal MDL and parallel state dockets.

The numbers underscore the stakes: the MDL added 1,739 pending cases in June alone - the largest single-month jump in MDL history - surging from 3,769 to 5,508 cases and vaulting the docket from 11th to 9th largest in the country.

FIFRA Preempts State Failure-to-Warn Claims: What Monsanto v. Durnell Means for PI Practitioners

No. 24-1068  |  Decided June 25, 2026  |  7-2  |  U.S. Supreme Court

In a 7-2 decision authored by Justice Brett Kavanaugh, the U.S. Supreme Court ruled that state-level lawsuits trying to hold Monsanto liable for failing to warn consumers about Roundup's health risks are expressly barred by federal pesticide law. The majority's logic hinged on FIFRA § 136v(b), which bars states from imposing labelling requirements “in addition to or different from” federal standards. Because the EPA had continuously approved Roundup's label without a cancer warning, the Court reversed a $1.25 million verdict won by Missouri farmer John Durnell.

Justice Ketanji Brown Jackson, in a sharp dissent joined by Justice Neil Gorsuch, argued the majority “misunderstands FIFRA's requirements… and ultimately leaves Durnell without a remedy for the significant harms he has suffered.”

The decision triggers dismissal of current warning-based lawsuits and blocks future failure-to-warn claims - the vast majority of Roundup filings to date. But the holding is explicitly narrow: design defect, manufacturing defect, fraudulent advertising, and risks the EPA never evaluated remain legally viable. The ruling also carries major implications for Monsanto's pending $7.25 billion nationwide class settlement, and it has already sparked bipartisan legislative pushback from Sen. Cory Booker and Rep. Anna Paulina Luna.

The Ultra-Processed Food Lawsuit Just Got Dismissed - Twice. Here's What That Means for the Litigation Ahead.

Martinez v. Kraft Heinz Company, Inc., et al.  |  No. 2:24-cv-05871  |  E.D. Pennsylvania  |  Dismissed with prejudice: June 30, 2026

Bryce Martinez's suit against Kraft Heinz, Coca-Cola, PepsiCo, and eight other food giants - hoped by Morgan & Morgan to become the “Big Tobacco” litigation of the 21st century - was permanently dismissed by Judge Mia Roberts Perez on June 30, 2026. It was the second dismissal: even a nearly 500-page amended complaint spanning 179 products failed to fix the same defect that sank the original filing in August 2025.

The court did not doubt the health risks of ultra-processed foods; it failed strictly on causation. Judge Perez ruled that plaintiffs cannot bypass product-specific “but-for” causation simply by suing an entire industry at once, and rejected alternative and market-share liability theories.

UPF litigation is far from dead. Seven other PI cases remain pending with far narrower defendant lists; Morgan & Morgan has already pivoted with Ford v. Kraft Heinz, a 321-page complaint detailing exact consumption data; and San Francisco's City Attorney is pursuing a public nuisance enforcement action that sidesteps individual causation entirely - a path many experts view as far more viable.

Your Client's Smartwatch Is Now a Witness - On Both Sides of the Table

Advising clients on digital footprints used to mean one thing: stay off social media. That is now the bare minimum. In 2026, defense investigators use smartwatch activity, GPS records, ride-share history, and vehicle data to challenge injury claims. With global wearable shipments topping 611 million units and nearly 30% of U.S. adults wearing a health tracker, your client almost certainly has one - and so does the defense's investigator.

A crash-detection alert with a heart rate spike and a sustained drop in daily steps can be powerful, objective evidence for a plaintiff. But the same device can just as easily tank a case - an intense workout logged a week after an alleged debilitating injury gives the defense exactly what it needs to attack credibility.

Bartis v. Biomet, Inc. stands as the foundational civil authority on wearable discovery: step-count data was ordered produced as relevant to a mobility claim, while sleep, heart rate, and location metrics were redacted as overly sensitive. In State v. Dabate, Fitbit data contradicted a murder suspect's alibi and secured a conviction the Connecticut Supreme Court affirmed in 2025 as reliable scientific evidence - a precedent that crosses cleanly into civil practice. And in Spoljaric v. Savarese, a New York court denied a defense request for Fitbit weight-loss data as an unsupported fishing expedition, giving plaintiffs' firms a real shield against overreach.

Add wearable device ownership to intake for every client, send preservation letters that specifically cover wearable data the moment litigation is foreseeable, and proactively review the data yourself before opposing counsel requests it.

The Voice of the Firm Wears a Paralegal Badge

Ask any client what frustrated them most about their PI case, and the answer is rarely the final settlement number. It is the silence in between - the unreturned calls, the weeks without an update, the feeling of being forgotten inside a massive system. According to Clio's Legal Trends Report, 64% of prospective clients chose not to hire a firm simply because the office failed to respond to an initial call or email, and 65% said they were never told what to expect next.

In most PI firms, the client talks to the paralegal far more than the attorney. That is not a gap in service - it is the design of a well-run practice. Clients who feel heard are easier to work with at depositions, more likely to follow through on treatment, and more likely to refer family and friends once the case settles.

High-impact communication is timely, substantive, and follows a rhythm the client can rely on - if you promise an update every two weeks, deliver it, even when there is nothing new to report. And know the ethical line: paralegals cannot give legal advice or discuss case value, but everything else - status updates, timelines, what an IME involves - is squarely in scope.